| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.45 | 2e-11 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.38 | 9e-08 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-07 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 4e-05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.21 | 0.0006 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |